Resistin and cardiovascular disease

Area of Science:

• Endocrinology and Metabolism
• Cardiovascular Research
• Biomarker Discovery

Background:

• Resistin, a hormone, is increasingly recognized for its association with cardiovascular diseases.
• Previous research links resistin to coronary atherosclerotic disease, congestive heart failure, and peripheral artery disease.
• Clinical literature generally supports resistin's connection to coronary and peripheral artery diseases, including ischemic stroke.

Purpose of the Study:

• To review the multifaceted roles of resistin in cardiovascular disease.
• To evaluate resistin's potential as a screening, diagnostic, and prognostic marker.
• To discuss the complexities and limitations of resistin's biomarker function.

Main Methods:

• Literature review of studies investigating resistin and cardiovascular disease.
• Analysis of clinical data supporting resistin's association with various cardiovascular conditions.
• Examination of confounding factors affecting resistin's predictive value.

Main Results:

• Resistin is implicated in coronary artery disease, congestive heart failure, peripheral artery disease, and ischemic stroke.
• Its utility as an independent predictor is challenged by confounders like C-reactive protein.
• The precise biomarker function of resistin in cardiovascular disease remains unclear.

Conclusions:

• Resistin plays a role in several cardiovascular diseases.
• Its independent value as a biomarker requires further investigation.
• Large-scale, prospective studies are essential to clarify resistin's role in cardiovascular disease prediction and diagnosis.